Astellas Today (Fiscal 2017/as of March 31, 2017)

As a global pharmaceutical company with its own distribution channels in more than 50 countries around the world, Astellas is developing business in a well-balanced manner across its four main regions of Japan, the Americas, EMEA and Asia & Oceania.

Item 1 Market capitalization (as of June 30, 2017) \2.8 trillion Item 2 Sales \1,311.7 billion Item 3 Core Operating Profit \274.6 billion Item 4 Core Operating Margin 20.9% Item 5 ROE 17.3%
"Item 1 Market capitalization (as of June 30, 2017) \2.8 trillion Item 2 Sales \1,311.7 billion Item 3 Core Operating Profit \274.6 billion Item 4 Core Operating Margin 20.9% Item 5 ROE 17.3%"
"Item 1 Market capitalization (as of June 30, 2017) \2.8 trillion Item 2 Sales \1,311.7 billion Item 3 Core Operating Profit \274.6 billion Item 4 Core Operating Margin 20.9% Item 5 ROE 17.3%"
"Item 1 Market capitalization (as of June 30, 2017) \2.8 trillion Item 2 Sales \1,311.7 billion Item 3 Core Operating Profit \274.6 billion Item 4 Core Operating Margin 20.9% Item 5 ROE 17.3%"